Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell–NK cell axis in murine hepatocellular carcinoma model
Shuai Wang, Qinchuan Wu, Tianchi Chen, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 467-478
Closed Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Zhou Chen, Fangfang Han, Yan Du, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 539
Emerging phagocytosis checkpoints in cancer immunotherapy
Yue Liu, Yanjin Wang, Yanrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 154
d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma
Shulan Han, Xueying Bao, Yifang Zou, et al.
Science Advances (2023) Vol. 9, Iss. 29
Open Access | Times Cited: 113
NK cells are never alone: crosstalk and communication in tumour microenvironments
Yongqiang Zhou, Cheng Lu, Lu Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 85
Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy target
Jiaxin Li, Jun Zhou, Huanhuan Huang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 48
NK cell-based tumor immunotherapy
Hao Zhang, Yang Li, Tingting Wang, et al.
Bioactive Materials (2023) Vol. 31, pp. 63-86
Open Access | Times Cited: 48
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 46
Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy
Yong Xi, Lijie Chen, Jian Tang, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 94-114
Closed Access | Times Cited: 44
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 44
Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity
Xueyao Wang, Rui Hu, Zhenwei Song, et al.
Cancer Letters (2022) Vol. 547, pp. 215880-215880
Closed Access | Times Cited: 49
Alleviating hypoxia to improve cancer immunotherapy
Peng Fan, Naidong Zhang, Eleonora Candi, et al.
Oncogene (2023) Vol. 42, Iss. 49, pp. 3591-3604
Closed Access | Times Cited: 37
Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway
Lili Cheng, Peng Zhang, Yadong Liu, et al.
Biomaterials (2023) Vol. 301, pp. 122259-122259
Closed Access | Times Cited: 33
NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential
Federica Portale, Diletta Di Mitri
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9521-9521
Open Access | Times Cited: 31
Tumour‐associated macrophages in gastric cancer: From function and mechanism to application
Jie Li, Juan Sun, Ziyang Zeng, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 23
The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
Tianye Li, Mengke Niu, Jianwei Zhou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 15
The role of dendritic cells in cancer immunity and therapeutic strategies
Yunze Tai, Man Chen, Fang Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111548-111548
Closed Access | Times Cited: 14
Targeting macrophages in cancer immunotherapy: Frontiers and challenges
Yue Liu, Huabing Tan, Jingyuan Dai, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
The Application of Dendritic Cells Vaccines in Tumor Therapy and Their Combination with Biomimetic Nanoparticles
Tong Zhu, Yuexin Li, Yutao Wang, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 337-337
Open Access | Times Cited: 1
Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing
Mei‐Ling Cheng, Guodong Liang, Zongyi Yin, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 9, pp. 5497-5512
Closed Access | Times Cited: 38
A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma
Aimin Jiang, Peng Luo, Ming Chen, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
A key driver to promote HCC: Cellular crosstalk in tumor microenvironment
Pengyue Liu, Kong Lingyu, Ying Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 17
Delivery of CD47-SIRPα checkpoint blocker by BCMA-directed UCAR-T cells enhances antitumor efficacy in multiple myeloma
Qizhong Lu, Donghui Yang, Hexian Li, et al.
Cancer Letters (2024) Vol. 585, pp. 216660-216660
Closed Access | Times Cited: 8
Application of adoptive cell therapy in hepatocellular carcinoma
Dengqiang Wu, Yujie Li
Immunology (2023) Vol. 170, Iss. 4, pp. 453-469
Open Access | Times Cited: 16
Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma
Tanghua Li, Jiapeng Jiao, Haoteng Ke, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Silencing of SIRPα enhances the antitumor efficacy of CAR-M in solid tumors
Han Zhang, Yi Huo, Wenjing Zheng, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 11, pp. 1335-1349
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top